
Sign up to save your podcasts
Or


The 2024 American Society of Clinical Oncology (ASCO) Annual Meeting featured five days of presentations and educational sessions on all types of cancer. Dr. Eleonora Teplinsky, a board-certified medical oncologist at the Valley-Mount Sinai Comprehensive Cancer Center in Paramus, NJ, summarizes the top breast cancer research.
Listen to the episode to hear Dr. Teplinsky explain:
the DESTINY- Breast06 study on Enhertu compared to chemotherapy for metastatic hormone-receptor-positive breast cancer
how circulating tumor DNA may help predict recurrence
descalating treatment to reduce the risk of side effects
By Breastcancer.org4.3
4242 ratings
The 2024 American Society of Clinical Oncology (ASCO) Annual Meeting featured five days of presentations and educational sessions on all types of cancer. Dr. Eleonora Teplinsky, a board-certified medical oncologist at the Valley-Mount Sinai Comprehensive Cancer Center in Paramus, NJ, summarizes the top breast cancer research.
Listen to the episode to hear Dr. Teplinsky explain:
the DESTINY- Breast06 study on Enhertu compared to chemotherapy for metastatic hormone-receptor-positive breast cancer
how circulating tumor DNA may help predict recurrence
descalating treatment to reduce the risk of side effects

22,010 Listeners

1,095 Listeners

2,041 Listeners

1,684 Listeners

2,621 Listeners

3,527 Listeners

9,242 Listeners

53 Listeners

4,379 Listeners

331 Listeners

373 Listeners

20,294 Listeners

1,183 Listeners

117 Listeners

30 Listeners